What is the "second technology" license?, page-23

I don't think so. Not so soon after it's appeared on databases.
I believe it is DCE and have long suspected Nurofen/Voltaren gels et al to be the next cab off the rank.
Compelling technology, not difficult to implement or understand, drop-in, uncomplicated and already an established market for the product.
I really hope it is someone other than Procter & Gamble. The market needs to see we are more than a one partner pony.